Aims & Scope
The Journal of Alzheimer’s Disease is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment and psychology of Alzheimer’s disease. The journal publishes research reports, reviews, short communications, book reviews, and letters-to-the-editor. The journal is dedicated to providing an open forum for original research that will expedite our fundamental understanding of Alzheimer’s disease.
In 2018, JAD celebrated its 20th anniversary (see details here).
In association with JAD, a number of book titles relating to Alzheimer's disease are published by IOS Press. These include the book that was published to commemorate the centennial in 2006 of Alois Alzheimer's discovery of what would become to be known as Alzheimer's disease, as well as the book series Advances in Alzheimer's Disease (AIAD), which has an always increasing number of titles. The forward-looking book in the AIAD series was published in July 2018 (to order click here) and the gut microbiome title in July 2022 (to order click here).
George Perry, PhD
University of Texas at San Antonio
One UTSA Circle
San Antonio, Texas 78249
Tel: +1 210 458 4450
Fax:+1 210 458 4445
Department of Pathology
Case Western Reserve University
2103 Cornell Road
Cleveland, Ohio 44106
Tel:+1 216 368 3671
Fax:+1 216 368 8964
Former Editor-in-Chief (2001–2010)
Jack de la Torre
M. Arfan Ikram
Jagannatha Rao Kosagisharaf
Full list of the Associate Editors at: j-alz.com/board.
Full list of the Editorial Board at: j-alz.com/board.
Cabell's Guide or Directory
Chemical Abstracts Service (CAS)
CSA Biological Sciences
CSA Illustrata Natural Sciences
CSA Neurosciences Abstracts
EVISA - European Virtual Institute for Speciation Analysis
OA @ PubMedCentral
Prous Science Integrity
Ulrich's Periodicals Directory
Web of Science: Biological Abstracts
Web of Science: BIOSIS Previews
Web of Science: Journal Citation Reports/Science Edition
Web of Science: Science Citation Index Expanded (SciSearch®)
By default, articles published in the Journal of Alzheimer’s Disease are available only to institutions and individuals with access rights. However, the journal offers all authors the option to purchase open access publication for their article as part of the IOS Press Open Library. This means that the final published version will be freely available to anyone worldwide, indefinitely, under a Creative Commons license and without the need to purchase access to the article. This is also referred to as “gold” open access.
Gold open access pricing
Authors who choose gold open access publication will be subject to an article publication charge of € 1500 / US$ 1700 for publication under the CC BY-NC 4.0 license or € 2200 / US$ 2500 for publication under the CC BY 4.0 license. Pricing is exclusive of possible taxes. After an article is accepted for publication, the corresponding author will be informed regarding the open access option during the production stages, and will have the opportunity to purchase open access for their article. It could be that the open access fee of an article is waived completely due an institutional agreement IOS Press has with the corresponding authors' institution. Please check the institutional agreements page for details.
Green open access
Authors who do not make use of the gold open access option may still make their article freely available using self-archiving, also referred to as green open access. Authors may make their final accepted manuscript available for free download from their personal or institutional website or institutional archive. This model is free for the author.
This journal deposits all open access articles in PubMedCentral (PMC) as part of the IOS Press Open Library. If an author chooses to publish their paper with open access then the publisher will deposit the article in PMC upon publication.
Social Media & Mailings – The Journal of Alzheimer's Disease (JAD) is on Facebook and Twitter, so be sure to follow us and be part of the conversation! JAD also issues regular newsletters; not signed up yet? You can do so here: tiny.cc/JADsignup. Read the recent newsletter here.
Discover our fully open access Alzheimer's journal – Perhaps you are also interested in JAD's sister journal, the open access Journal of Alzheimer's Disease Reports? See the contents here, and click here to view the newsletter of JADR Volume 6 for content published in Q1 2022.
JAD 20th Anniversary – During 2018, JAD had its 20th anniversary and to mark this occasion an open access issue of the journal was published in Vol.62, Iss.3 (view here). To read our special commorative publication, click here (PDF). Read our anniversary year summary here!
Discover the contents of the latest journal issue:
Communicating and Using Dementia Risk Evidence
Allyson C. Rosen
Disclosing Individual Results in Dementia Research: A Proposed Study Participant’s Bill of Rights
Angela Taylor, Sarah Walter, Jamie Tyrone, Sara Langer, John-Richard Pagan, Cynthia Huling Hummel, Bonnie M. Wheaton, Doris T. Zallen, Allyson C. Rosen
The Advisory Group on Risk Evidence Education for Dementia: Multidisciplinary and Open to All
Jalayne J. Arias, Allyson C. Rosen, J. Wesson Ashford, Deborah Blacker, Jasmeer P. Chhatwal, Nathan A. Chin, Lindsay Clark, Sharon S. Denny, Jill S. Goldman, Carey E. Gleason, Joshua D. Grill, Judith L. Heidebrink, Victor W. Henderson, James A. Lavacot, Jennifer H. Lingler, Malavika Menon, Rachel L. Nosheny, Fabricio F. Oliveira, Monica W. Parker, Annalise Rahman-Filipiak, Anwita Revoori, Malia C. Rumbaugh, Danurys L. Sanchez, Suzanne E. Schindler, Christopher G. Schwarz, Leslie Toy, Jamie Tyrone, Sarah Walter, Li-san Wang, Ellen M. Wijsman, Doris T. Zallen, Neelum T. Aggarwal,
A Blood Test for Alzheimer’s Disease: It’s about Time or Not Ready for Prime Time?
Joshua D. Grill, Douglas R. Galasko, Jennifer H. Lingler, Judith L. Heidebrink,